Vaccination rates plummet

 Vaccination rates have dropped to a record low

According to updated data from the Ministry of Health, published on Sunday evening, 581 people have died in Israel as a result of infection with coronavirus since the beginning of the month.

According to preliminary data, 63 patients died over the weekend .

Since the beginning of the year, 1,287 people have died as a result of infection with coronavirus, which is, on average, about 30 per day. Since the beginning of the epidemic, 9,544 patients have died.

Since January, 2,036,773 cases of infection have been diagnosed in Israel, which means that almost one in four Israelis have been diagnosed with the virus in the last 44 days. This number appears to be higher as many did not know they tested positive for coronavirus or chose not to be officially tested.

The number of seriously ill patients, which stood at 999 on Saturday evening, has risen to 1,056, of which 285 are on ventilators.

In Israel today there are about 283,000 patients, most of them in a mild condition. Of those infected, 18,431 live in Jerusalem, 14,143 in Tel Aviv-Yafo, 9,514 in Haifa, 9,214 in Beersheba, 9,124 in Petah Tikva, 7,715 in Rishon Lezion, 6,667 in Netanya, 6 127 in Ashkelon, 5969 in Ashdod, 5499 in Holon, 5493 in Rehovot, 4723 in Ramat Gan, 4079 in Hadera, 3320 in Bat Yam, 3291 in Modiin Makkabim Reut, 3110 in Nazareth, 3084 in Herzliya and 3055 in Rosh HaAyin.

And in the Vaccine Department, negative results were recorded on Saturday for all doses. Only 21 Israelis received their first dose of the vaccine, compared to 61 last Saturday and 124 on Saturday two weeks ago. The second portion was given to 79 people, compared to 198 last Saturday. And 185 received a fourth dose of the vaccine, up from 416 last Saturday.

Israel will participate in Pfizer's trial of a vaccine adapted against the Omicron variant, which is expected to launch later this month.

Talks have been underway in recent weeks between the US pharmaceutical giant and Israeli health officials.
Israel is joining a global experiment with a new vaccine designed to prevent infection and serious illness with the Omicron strain, which is considered much more more contagious than Delta.

Add a Comment

Your email address will not be published.